2021 Forecast: Global Neuromodulation Market

Latest Report Available at Orbis research Neuromodulation Market provides pin-point analysis for changing competitive dynamics and a forward looking perspective on different factors driving or restraining industry growth.

The Global market for Neuromodulation is projected to reach more than US$5 Billion by the end of 2021 growing at a CAGR of around XX% from 2016 to 2021.

Request sample copy of this report at Neuromodulation Market Research Report

Market growth can be attributed to factors such as rising geriatric population, increasing prevalence of neurological diseases, strong product pipeline offered by the players. In addition, rapid advances in the field of neuromodulation and development of minimally invasive techniques have greatly expanded the market. High cost of treatment and negative social perception is restraining the growth of neuromodulation market.

North America is seen as the dominant player in the neuromodulation market followed by Europe, Asia–Pacific, and rest of the world (RoW) in 2015. In the coming years, the neuromodulation market is expected to witness the highest growth rate in the Asian region, with emphasis on India, China, and Japan. These countries are expected to increase revenues for the manufacturers of devices involved in neuromodulation.

Spinal cord stimulation segment dominated the neuromodulation market with more than XX% share in 2015. But its market share will dwindle in the forecasting period due to the highest growth rate of deep brain stimulation. It is expected that deep brain stimulation will grasp nearly 20% market share by the year end of 2021.

Chronic Pain is identified as the largest application segment of the neuromodulation market. Urinary and Fecal Incontinence(UFI) is the second leading segment for neuromodulation market. Refractory epilepsy stands at the third spot with more than XX% share in 2015. Parkinson’s disease holds the fourth highest share being followed by Gastroparesis. Essential Tremor and Dystonia are the other leading application segment for neuromodulation market.

Purchase a copy of Neuromodulation Market visit @  http://www.orbisresearch.com/contact/purchase/187212  For more information contact sales@orbisresearch.com     .

Further, prudent analysis has been done on the competitor’s part, where three major players grab XX% of the global market by revenue. Medtronic, Boston Scientific, St Jude Medical, Liva Nova and Nevro are the key influencers with their products in the Neuromodulation market. Merger & acquisitions, partnerships, collaborations and extending distribution networks are few important factors for their dominance.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry–validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, application, technology, geographies, companies and competitive landscape. The report concludes with the profiles of major players in the global neuromodulation such as Medtronic, Boston Scientific, St Jude Medical, Liva Nova and Nevro. The major market players are evaluated on various parameters such as company overview, product portfolio, and sales analysis of neuromodulation segment from 2010 to 2021. The report also entails major drivers and challenges of neuromodulation market.

Neuromodulation Market: Segmentation
Neuromodulation market is classified on the basis of technology, application, company and geography.

Based on Technology, Neuromodulation market can be segmented as follows:
Spinal Cord Stimulation
Deep Brain Stimulation
Sacral Nerve Stimulation
Vagus Nerve Stimulation
Other Technologies

Based on Application, Neuromodulation market can be segmented as follows:
Chronic Pain
Parkinson’s Disease
Urinary Fecal Incontinence
Refractory Epilepsy
Essential Tremor
Dystonia
Gastroparesis
Treatment Resistant Depression(TRD)
Obsessive Compulsive Disorder(OCD)
Other Applications

Based on Geography, Neuromodulation market can be segmented as follows:
North America
Europe
Asia Pacific
Latin America
Rest of the World (ROW)

Based on Company, Neuromodulation market can be segmented as follows:
Medtronic
Boston Scientific
St Jude Medical
Liva Nova(Cyberonics)
Nevro

Browse Complete Report @ http://www.orbisresearch.com/reports/index/neuromodulation-market-by-application-technology-region-and-company-and-forecast-to-2021-global-analysis .

Some points from TOC:

1. Executive Summary

2. Global – Neuromodulation Market & Forecast (2010 – 2021)

3. Global – Neuromodulation Market Share Outlook
3.1 By Technology – Neuromodulation Market Share Outlook
3.2 By Region – Neuromodulation Market Share Outlook
3.3 By Application – Neuromodulation Market Share Outlook
3.4 By Company – Neuromodulation Market Share Outlook

4. Global Neuromodulation Market – By Technology (2010 – 2021)
4.1 Overall Neuromodulation Market & Forecast – By Technology
4.2 Spinal Cord Stimulation Market Revenue & Forecast
4.3 Deep Brain Stimulation Market Revenue & Forecast
4.4 Sacral Nerve Stimulation Market Revenue & Forecast
4.5 Vagus Nerve Stimulation Market Revenue & Forecast
4.6 Other Technologies Market Revenue & Forecast

5. Global Neuromodulation Market – By Regional Outlook (2010 – 2021)
5.1 Region wise – Overall Neuromodulation Market Revenue & Forecast
5.2 North America – Neuromodulation Market Revenue & Forecast
5.3 Europe – Neuromodulation Market Revenue & Forecast
5.4 Asia Pacific – Neuromodulation Market Revenue & Forecast
5.5 Latin America – Neuromodulation Market Revenue & Forecast
5.6 Rest of the World (ROW) – Neuromodulation Market Revenue & Forecast

6. Global Neuromodulation Market – By Application (2010 – 2021)
6.1 By Application – Overall Neuromodulation Market Revenue & Forecast
6.2 Chronic Pain – Neuromodulation Market & Forecast
6.3 Parkinson’s Disease – Neuromodulation Market & Forecast
6.4 Urinary Fecal Incontinence – Neuromodulation Market & Forecast
6.5 Refractory Epilepsy – Neuromodulation Market & Forecast
6.6 Essential Tremor – Neuromodulation Market & Forecast
6.7 Dystonia – Neuromodulation Market & Forecast
6.8 Gastroparesis – Neuromodulation Market & Forecast
6.9 Treatment Resistant Depression(TRD) – Neuromodulation Market & Forecast
6.10 Obsessive Compulsive Disorder(OCD) – Neuromodulation Market & Forecast
6.11 Other Application – Neuromodulation Market & Forecast

7. Competitive Landscape
7.1 Mergers & Acquisitions
7.2 Agreements, Collaborations & Partnerships

 For any enquires before buying, connect with us @ enquiry@orbisresearch.com

About Us:

Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Contact Information:

Hector Costello

Senior Manager – Client Engagements

4144N Central Expressway,

Suite 600, Dallas,

Texas – 75204, U.S.A.

Phone No.: +1 (214) 884-6817; +9164101019

Follow Us on LinkedIn: https://www.linkedin.com/company/orbis-research

Follow us on Twitter: https://twitter.com/orbisresearch

Like us on Facebook: https://www.facebook.com/pages/Orbis-Research/820969017982115